Arbaclofen in fragile X syndrome: results of phase 3 trials

被引：0
|
作者：
Elizabeth Berry-Kravis
Randi Hagerman
Jeannie Visootsak
Dejan Budimirovic
Walter E. Kaufmann
Maryann Cherubini
Peter Zarevics
Karen Walton-Bowen
Paul Wang
Mark F. Bear
Randall L. Carpenter
机构：
[1] Rush University Medical Center,Departments of Pediatrics, Neurological Sciences, Biochemistry
[2] University of California Davis Medical Center,MIND Institute and Department of Pediatrics
[3] Emory University,Department of Human Genetics
[4] Kennedy Krieger Institute,Departments of Psychiatry &Behavioral Sciences
[5] the Johns Hopkins Medical Institutions,Department of Neurology, Boston Children’s Hospital
[6] Boston,undefined
[7] MA 02115 and Greenwood Genetic Center,undefined
[8] Seaside Therapeutics Inc,undefined
[9] Simons Foundation Autism Research Initiative,undefined
[10] Autism Speaks,undefined
[11] The Picower Institute for Learning and Memory,undefined
[12] Massachusetts Institute of Technology,undefined
[13] Rett Syndrome Research Trust,undefined
来源：
Journal of Neurodevelopmental Disorders | 2017年 / 9卷
关键词：
Fragile X syndrome; Arbaclofen; GABA agonist; FMR1; Targeted treatment; Neurodevelopmental disorder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] High Functioning Male with Fragile X Syndrome and Fragile X-Associated Tremor/Ataxia Syndrome
    Basuta, Kirin
    Schneider, Andrea
    Gane, Louise
    Polussa, Jonathan
    Woodruff, Bryan
    Pretto, Dalyir
    Hagerman, Randi
    Tassone, Flora
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (09) : 2154 - 2161
  • [22] Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
    Luu, Skylar
    Province, Haley
    Berry-Kravis, Elizabeth
    Hagerman, Randi
    Hessl, David
    Vaidya, Dhananjay
    Lozano, Reymundo
    Rosselot, Hilary
    Erickson, Craig
    Kaufmann, Walter E.
    Budimirovic, Dejan B.
    BRAIN SCIENCES, 2020, 10 (09) : 1 - 17
  • [23] Incidence of Fragile X syndrome in Ireland
    O'Byrne, James J.
    Sweeney, Michael
    Donnelly, Deirdre E.
    Lambert, Deborah M.
    Beattie, Eleanor D.
    Gervin, Celine M.
    Barton, David E.
    Lynch, Sally A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (03) : 678 - 683
  • [24] Animal model for fragile X syndrome
    Oostra, BA
    Hoogeveen, AT
    ANNALS OF MEDICINE, 1997, 29 (06) : 563 - 567
  • [25] Motor stereotypies in fragile X syndrome
    Kaytser, Victor
    Berry-Kravis, Elizabeth
    Ouyang, Bichun
    Doll, Emily
    Hall, Deborah A.
    JOURNAL OF PEDIATRIC NEUROLOGY, 2014, 12 (01) : 29 - 34
  • [26] Molecular Biomarkers in Fragile X Syndrome
    Zafarullah, Marwa
    Tassone, Flora
    BRAIN SCIENCES, 2019, 9 (05)
  • [27] Translational endpoints in fragile X syndrome
    de Esch, Celine E. F.
    Zeidler, Shimriet
    Willemsen, Rob
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 256 - 269
  • [28] Fragile X syndrome: An aging perspective
    Schneider, Andrea
    Ligsay, Andrew
    Hagerman, Randi J.
    DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2013, 18 (01) : 68 - 74
  • [29] Advances in the Treatment of Fragile X Syndrome
    Hagerman, Randi J.
    Berry-Kravis, Elizabeth
    Kaufmann, Walter E.
    Ono, Michele Y.
    Tartaglia, Nicole
    Lachiewicz, Ave
    Kronk, Rebecca
    Delahunty, Carol
    Hessl, David
    Visootsak, Jeannie
    Picker, Jonathan
    Gane, Louise
    Tranfaglia, Michael
    PEDIATRICS, 2009, 123 (01) : 378 - 390
  • [30] Targeted treatments in fragile X syndrome
    Hare, Emma B.
    Hagerman, Randi J.
    Lozano, Reymundo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 531 - 543
12345